β3-AR agonists can stimulate human BAT activity in normal weight adults [5], but this ability was impaired in people with obesity [10] tested via 18F-FDG PET/CT detection. The gene discussed is ADRB3; the disease is obesity due to melanocortin 4 receptor deficiency.